132 related articles for article (PubMed ID: 8918605)
1. Toward understanding the molecular pathogenesis of monoclonal immunoglobulin light-chain deposition.
Bellotti V; Merlini G
Nephrol Dial Transplant; 1996 Sep; 11(9):1708-11. PubMed ID: 8918605
[No Abstract] [Full Text] [Related]
2. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease.
Buxbaum J
Hematol Oncol Clin North Am; 1992 Apr; 6(2):323-46. PubMed ID: 1582976
[TBL] [Abstract][Full Text] [Related]
3. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease.
Kaplan B; Ramirez-Alvarado M; Sikkink L; Golderman S; Dispenzieri A; Livneh A; Gallo G
Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171
[TBL] [Abstract][Full Text] [Related]
4. [Light chain deposition disease].
Kanoh T
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):585-7. PubMed ID: 9851224
[No Abstract] [Full Text] [Related]
5. [Systemic light chain amyloidosis - molecular basis and clinical perspectives].
Schönland SO; Moos M; Bochtler T; Ho AD; Hegenbart U
Dtsch Med Wochenschr; 2009 Sep; 134(39):1949-52. PubMed ID: 19760558
[No Abstract] [Full Text] [Related]
6. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
Bellotti V; Mangione P; Merlini G
J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
Ronco P; Plaisier E; Mougenot B; Aucouturier P
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
[TBL] [Abstract][Full Text] [Related]
8. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease.
Kaplan B; Livneh A; Gallo G
Br J Haematol; 2007 Mar; 136(5):723-8. PubMed ID: 17223908
[TBL] [Abstract][Full Text] [Related]
9. Recurrent light and heavy chain deposition disease after renal transplantation.
Alchi B; Nishi S; Iguchi S; Shimotori M; Sakatsume M; Ueno M; Narita I; Saito K; Takahashi K; Gejyo F
Nephrol Dial Transplant; 2005 Jul; 20(7):1487-91. PubMed ID: 15840680
[No Abstract] [Full Text] [Related]
10. Pulmonary light chain deposition disease: report of five cases and review of the literature.
Bhargava P; Rushin JM; Rusnock EJ; Hefter LG; Franks TJ; Sabnis SG; Travis WD
Am J Surg Pathol; 2007 Feb; 31(2):267-76. PubMed ID: 17255772
[TBL] [Abstract][Full Text] [Related]
11. [Detection of monoclonal plasma cells in bone marrow and spleen of primary amyloidosis].
Katayama Y; Sakai A; Nobuyoshi M; Shimomura T; Kimura A
Rinsho Ketsueki; 2001 Sep; 42(9):705-9. PubMed ID: 11680983
[TBL] [Abstract][Full Text] [Related]
12. Lambda light chain deposition disease presenting as an amyloid-like arthropathy.
Rivest C; Turgeon PP; Senécal JL
J Rheumatol; 1993 May; 20(5):880-4. PubMed ID: 8336318
[TBL] [Abstract][Full Text] [Related]
13. [Immunoglobulin amyloidosis].
Hermine O; Bourquelot P; Buzyn A; Aucouturier P
Rev Prat; 1997 Oct; 47(16):1787-91. PubMed ID: 9453204
[TBL] [Abstract][Full Text] [Related]
14. Interaction between glycosaminoglycans and immunoglobulin light chains.
Jiang X; Myatt E; Lykos P; Stevens FJ
Biochemistry; 1997 Oct; 36(43):13187-94. PubMed ID: 9341206
[TBL] [Abstract][Full Text] [Related]
15. Systemic amyloidoses.
Blancas-Mejía LM; Ramirez-Alvarado M
Annu Rev Biochem; 2013; 82():745-74. PubMed ID: 23451869
[TBL] [Abstract][Full Text] [Related]
16. Role of immunoglobulin light chains in the pathogenesis of amyloid polyneuropathy associated with occult plasma-cell dyscrasia.
Dalakas MC; Engel WK
Trans Am Neurol Assoc; 1979; 104():227-9. PubMed ID: 233329
[No Abstract] [Full Text] [Related]
17. [Pulmonary diseases and non-amyloid light chain deposition].
Colombat M; Stern M
Rev Mal Respir; 2013 Sep; 30(7):524-6. PubMed ID: 24034455
[No Abstract] [Full Text] [Related]
18. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report.
Miyazaki D; Yazaki M; Gono T; Kametani F; Tsuchiya A; Matsuda M; Takenaka Y; Hosh Y; Ikeda S
Amyloid; 2008 Jun; 15(2):125-8. PubMed ID: 18484339
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains.
Preud'homme JL; Aucouturier P; Touchard G; Striker L; Khamlichi AA; Rocca A; Denoroy L; Cogné M
Kidney Int; 1994 Oct; 46(4):965-72. PubMed ID: 7861722
[No Abstract] [Full Text] [Related]
20. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.
Gertz MA; Comenzo R; Falk RH; Fermand JP; Hazenberg BP; Hawkins PN; Merlini G; Moreau P; Ronco P; Sanchorawala V; Sezer O; Solomon A; Grateau G
Am J Hematol; 2005 Aug; 79(4):319-28. PubMed ID: 16044444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
